Evercore ISI on Wednesday forecast the S&P 500 will rise to 6,600 by mid-2025, saying a "decisive and uncontested" win by ...

Property and casualty insurers, as well as life insurers, are expected to benefit from Donald Trump's presidential election ...

The president and CEO of Evercore Wealth Management and Evercore Trust explains how he built a business to serve the complex ...

In a report released today, Michael Binetti from Evercore ISI reiterated a Buy rating on Ferrari (RACE – Research Report), with a price ...

In a report released today, Glenn Schorr from Evercore ISI maintained a Buy rating on Apollo Global Management (APO – Research Report), ...

Sarah Bianchi, Evercore ISI chief strategist of political affairs and public policy, says some of the exit-poll data are ...

Proxies for former President Donald Trump's trade policies — specifically bitcoin and the Chinese yuan — can help gauge what market participants are making of the election results, Julian Emanuel, ...

Despite witnessing modest growth in demand over the past three months, Apellis Pharmaceuticals’ complement inhibitor for ...

Overall, the bull market “looks to remain intact,” Evercore’s team emphasizes. However, it adds that the S&P 500 index has the potential for a post-election “meltup” to 6,500 or experience a sell-off.

In its second full quarter on the market, the fatty liver disease drug racked up sales of $62 million, which routed Wall ...

Evercore ISI upgraded shares of Apellis Pharmaceuticals (NASDAQ:APLS – Free Report) to a strong-buy rating in a report issued on Thursday, Zacks.com reports. APLS has been the topic of a number ...